ClinVar Miner

Submissions for variant NM_004407.4(DMP1):c.815G>A (p.Arg272His)

gnomAD frequency: 0.00202  dbSNP: rs145237146
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000764554 SCV000451505 uncertain significance Hypophosphatemic rickets, autosomal recessive, 1 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Eurofins Ntd Llc (ga) RCV000591260 SCV000705349 uncertain significance not provided 2017-01-26 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV000764554 SCV000895642 uncertain significance Hypophosphatemic rickets, autosomal recessive, 1 2018-10-31 criteria provided, single submitter clinical testing
Invitae RCV000591260 SCV001117423 benign not provided 2024-01-31 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000591260 SCV004152950 likely benign not provided 2023-02-01 criteria provided, single submitter clinical testing DMP1: BP4, BS2
PreventionGenetics, part of Exact Sciences RCV003902356 SCV004724166 likely benign DMP1-related condition 2022-10-18 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Department of Pathology and Laboratory Medicine, Sinai Health System RCV000591260 SCV001551624 likely benign not provided no assertion criteria provided clinical testing The DMP1 p.Arg272His variant was not identified in the literature nor was it identified in LOVD 3.0. The variant was identified in dbSNP (ID: rs145237146) and ClinVar (classified as uncertain significance by Illumina, EGL Genetic Diagnostics and Fulgent Genetics, and as benign by Invitae). The variant was identified in control databases in 531 of 281746 chromosomes (1 homozygous) at a frequency of 0.001885 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: Latino in 145 of 35372 chromosomes (freq: 0.004099), Other in 21 of 7198 chromosomes (freq: 0.002917), European (non-Finnish) in 330 of 128426 chromosomes (freq: 0.00257), Ashkenazi Jewish in 14 of 10324 chromosomes (freq: 0.001356), African in 8 of 24814 chromosomes (freq: 0.000322), South Asian in 9 of 30580 chromosomes (freq: 0.000294), European (Finnish) in 3 of 25114 chromosomes (freq: 0.00012), and East Asian in 1 of 19918 chromosomes (freq: 0.00005). The p.Arg272 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.